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ABSTRACT
Background: Cervical cancer can be prevented and mortality/morbidity reduced by 
early detection and referral. Developing countries are likely to benefit from more cost 
effective methods of screening and treatment. Visual inspection with acetic acid and 
Lugol`s iodine (VIA/VILI) offers a see and treat solution thus an affordable and efficient 
way to identify pre-malignant lesions. Immediate treatment with cryotherapy can be 
offered if pre-malignant lesions are found on visual inspection. Cryotherapy is a simple 
procedure that is curative for dysplasia; it is likely to benefit cervical dysplasia cases 
picked early in resource poor settings, however there are several factors that hinder 
patients’ access to this noble technique. 
Objective: Determine hindrances to cryotherapy for patients following positive results 
of VIA/VILI after referral.
Design: Cross sectional Study
Setting: Khwisero, Western Kenya. 
Subjects: Women attending a medical camp, willing to get screened for cervical cancer.
Results: One hundred and nine patients were screened; seventy three (66.97%) were 
negative for VIA/VILI, twenty one (19.26%) were positive and referred for cryotherapy. 
Reasons for lack of follow up were financial constraints, lack of medical personnel at 
referral centres and poor access to the referral facilities.19.26% of women identified 
with positive lesions required intervention. No patient received cryotherapy following 
referral.
Conclusion: There is urgent need for availability of cryotherapy machines and training 
of personnel who can perform cryotherapy at the primary care   level.  Regional studies 
on knowledge attitudes and practices about VIA/VILI and cryotherapy are required 
to provide reasons for the poor uptake of this procedure.
INTRODUCTION
Each year cervical cancer is diagnosed in nearly 
half a million women, and more than 260,000 die of 
the disease (1). Screening programs and treatment 
of precancerous cervical abnormalities can reduce 
mortality, but have not been deployed effectively 
in the developing world (2). As a result, 93 percent 
of the overall mortality from cervical cancer occurs 
outside of the thirty-four wealthiest countries (3).
 Within developing regions, Africa carries a 
larger burden of the disease (4). Africa experiences 
the highest number of new cases of and deaths 
from, cervical cancer in a year. According to the 
World Health Organisation (WHO), the incidence 
of cervical cancer in Africa is 80,419 while deaths 
are approximately 53,334 per year (5).  Although it 
is evident that the rate of incidence of cervical cancer 
is very high in sub-Saharan Africa, the incidence of 
cervical cancer in many African countries is unknown 
due to gross under reporting (6).
 In SSA, cervical cancer affects mostly women in 
the 20-40 year age group. It accounts for 22.2% of all 
cancers in women and it is also the most common 
cause of cancer death among women it affects Women 
in SSA lose more years to cervical cancer than to any 
other type of cancer and it affects women at a time 
in their life when they are critical to the social and 
economic stability of their families (5).
 The incidence of cervical cancer and mortality 
rates have declined substantially in Western countries 
following the introduction of screening programmes. 
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Screening programmes in Africa, however, are often 
undeveloped or non-existent, thereby affecting the 
survival rate of women (4). The survival rate for 
cervical cancer in SSA in 2002 was 21% compared 
with 70% and 66% in the United States and Western 
Europe respectively (6).
 Some of the risk factors or determinants of cervical 
cancer that contribute to the high mortality and low 
survival rates in Sub-Saharan Africa include: poor 
access to medical facilities (worst in the rural areas, 
where 60–70% of women who develop cervical cancer 
reside); poor nutrition and co-morbid conditions such 
as HIV infection (7); late presentation of the disease; 
large tumour at presentation; poor quality of care 
provided by many health services; and women not 
completing treatment due to challenges of poverty. 
 Developing countries are likely to benefit 
from more cost effective methods of screening and 
treatment. In developing countries, traditional pap 
smears have remained unaffordable for most and 
follow up of results from pap smears/biopsies are 
poorly handled in resource poor settings due to the 
scarcity of equipped laboratories and pathologists to 
review specimen (8). Various modes of treatment for 
premalignant lesions include LLETZ and cryotherapy. 
Seventy percent of of pre-invasive and invasive 
cervical neoplasia(9)  are associated with HPV  type 16 
and 18. Over eighty HPV types have been sequenced, 
although more than 200 types  exist based on data 
from partially sequenced DNA fragments(10).HPV-16 
accounts for more than 50% to 60% of cervical cancer 
cases followed by HPV-18(10%–12%) and HPV 31 
and 45 (4%–5% each) high risk types (11). HPV types 
associated with genital warts, such as HPV-6, and 
HPV-11, are referred to as low risk because they are 
rarely associated with malignant disease.. Infection 
of the cervical epithelium with high-risk types of 
HPV plays a key role in the pathogenesis of cervical 
cancer and its precursor lesions, although very 
few women infected with HPV ultimately develop 
cervical cancer (12). HPV invades the basal cells of 
the cervical epithelium at the transformation zone. 
High-risk viral types usually integrate their DNA 
into the host genome. HPV viral oncogenes E6 and 
E7 inhibit the action of tumor suppressor genes p53 
and the retinoblastoma gene; this activity prevents 
repair of DNA damage and programmed cell death, 
enabling proliferation of damaged cells and resultant 
tumorgenesis (13).
 HPV infection  in young women is frequent, but 
is transient in the large majority of women, persistence 
of high-risk types of HPV is a pre-requisite for the 
development of cervical intraepithelial neoplasia 
(CIN) 3 lesions and invasive cervical cancers although 
the biological reasons that determine persistence in 
individual women are poorly understood. Cofactors 
that further increase the risk of invasive cancer among 
HPV DNA positive women include old age, long-term 
use of oral contraceptives (five or more years), high 
parity (five or more full-term pregnancies), smoking, 
and HIV infection (14,15). Many factors initially 
thought to be associated with cervical cancer—for 
example, number of sexual partners—likely are 
indicators of HPV exposure rather than independent 
risk factors.
 There is strong evidence to support a multistep 
model of cervical cancer pathogenesis that involves, 
as the first step, infection with high-risk types of HPV. 
The median duration of HPV infection is about one 
year for high-risk types of HPV and shorter for the 
low-risk types (15). Many women with transient HPV 
infections will develop cytological abnormalities, 
although CIN 1 lesions have a high rate of spontaneous 
regression in the absence of treatment. CIN 3 lesions 
and carcinoma in situ have lower rates of spontaneous 
regression. The rates of progression and regression 
of CIN 2 lesions appears to fall between that of 
CIN 1 and CIN3 lesions.
 The latency period between HPV infection and 
the multistep process of development of dysplasia 
offers a golden opportunity to detect cervical cancer 
and possibly offer  intervention. Methods of screening 
utilized include  the Pap smear, Visual Inspection 
using Acetic acid / Lugol´s iodine, Liquid based 
cytology and HPV-DNA tests.  Since its introduction 
more than 50 years ago, the Pap  smear has been 
used throughout the world to identify precancerous 
lesions for treatment or follow-up. Routine use of 
Pap smear screening in the industrialized world has 
contributed to the 70% to 80% reduction of cervical 
cancer incidence in developed countries (16). In 
the United States, where an overall decline in the 
number of cervical cancer cases has occurred, rates 
nonetheless remain high in impoverished areas (17). 
Lack of similar success in developing countries can be 
attributed to limited resources (i.e., supplies, trained 
personnel, equipment, quality control, health care 
infrastructure, and effective follow-up procedures)
(21). 
An accessible and affordable cervical cancer 
screening method is VIA/VILI.A patient who screens 
positive may be offered cryotherapy for treatment. 
An advantage to this is that VIA/VILI  may be 
done by a variety of health care workers including 
doctors, nurses , midwives and clinical officers. It 
is inexpensive  requiring  a speculum, light source, 
acetic acid, Lugols iodine and eliminates the need 
for expensive laboratory tissue diagnosis. A study 
by Mabeya and  Orango 2009 (18), at Moi teaching 
and referral hospital Western Kenya compared the 
sensitivity and specificity of VIA versus Papsmear 
in HIV infected Women, they found Using cervical 
intraepithelial neoplasia (CIN) 2 or higher disease 
on biopsy as an end point, VIA had a sensitivity of 
69.6% (CI=55.1–81.0%), specificity of 51.0% (CI=41.5–
60.4%), PPV of 38.6% (CI=28.8–49.3%) and NPV of 
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79.1% (CI=67.8–87.2%). For conventional Pap smear, 
sensitivity was 52.5% (CI=42.1–71.5%), specificity 
66.3% (CI=52.0–71.2%), PPV 39.7% (CI=27.6–51.8%), 
and NPV 76.8% (CI=67.0–85.6%).
 Another study in Thailand 2002 (19) compared 
the costs and benefits of different strategies and 
their effectiveness in saving lives in a less developed 
country.  They compared VIA, Human papilloma 
virus testing, and pap smear screening. It was 
found that VIA performed at five-year intervals in 
women aged 35 to 55 with immediate treatment if 
abnormalities were found was the least expensive 
option and saved the greatest number of lives.
 Cryotherapy can be offered immediately at the 
same sitting after VIA/VILI provided a cryotherapy 
machine is available and in working order. VIA/VILI 
and cryotherapy  offers a see and treat approach at 
a single sitting, curtailing the drawbacks of a pap 
smear that  require high laboratory costs and need 
for follow up of results .This require finances that are 
inaccessible to the lower socio-economic population 
at greatest risk.  
 The World Health Organisation currently 
recommends that cryotherapy should be used rather 
than no treatment in cases of CIN; especially in settings 
where LEEP is not available. A Cochrane review in 
2013   on  the effectiveness and safety of alternative 
surgical treatments for CIN revealed no significant 
difference in treatment failures  or operative morbidity 
(20). Visual inspection with acetic acid and lugol`s 
iodine offers an affordable and efficient way to identify 
premalignant lesions followed by treatment with 
cryotherapy in a see and treat approach.The benefits 
of using cryotherapy to treat dysplasia in resource 
poor setting are several,first, it can be done by all 
cadres of health care providers including doctors, 
nurses, midwives, and clinical officers. secondly, it 
does not require anaesthesia , electricity is not needed 
and finally it is relatively inexpensive (21). 
 A final report by Western Kenya cervical cancer 
prevention project in 2004 concluded  that majority of 
women did not adhere to follow up due to travel costs, 
fear of cancer,  its treatment and poor partner support 
(21). No studies are available regarding screening of 
women during a medical camps to establish follow 
up  thereafter, majority of the work done  stems 
from  private and public collaborations and not free 
medical camps. We carried out a cross sectional study 
in Khwisero County; Western Kenya to establish the 
hindrances towards accessing treatment following 
referral when visual inspection with Lugol`s Iodine 
and Acetic acid was positive.
MATERIALS AND METHODS
Cervical cancer screening was carried out using 
VIA/VILI among women who had been mobilised 
to attend a  medical camp.VIA gives immediate 
results  but requires training and supervision,   all 
medical personnel undertaking the procedure at the 
medical camp were taken through refresher training 
on VIA/VILI and were certified by a senior lecturer 
and instructor from the Department of Obstetrics and 
Gynaecology Aga Khan University Hospital. A project 
in Harare Zimbabwe  on VIA  (22) required continued 
support supervision and attendance of more than one 
training session to ensure proficiency in  provision 
of VIA. Other strategies to maintain standards on 
reporting  included both in house  and pre – service 
training of doctors and nurses within facilities (22).
This underscores the importance of continuous and 
supervised training on VIA to ensure reproducibility 
of results  during screening.
 The procedure was carried out in a single room 
divided into two examination rooms . Each partition 
was equipped with an examination couch, desk, 
Lugol`s iodine and acetic acid.
 The heath care provider  undertaking the 
procedure had an 80 watt overhead lamp strapped 
across their forehead to aid in examination during a 
single examination. 
 We excluded all women who had obvious 
cervical masses, suspicious cancer, prolapsed fibroids 
or polyps.
 We performed VIA/VILI and if the result was 
positive, referred them to the nearest centre which we 
offered cryotherapy (Kakamega provincial hospital) 
or recommended regular checks-ups if it was normal.
Using standard interpretation guides, a positive VIA 
outcome was defined as “sharp, distinct, well-defined, 
dense (opaque, dull, or, oyster white) acetowhite 
areas with or without raised margins, abutting the 
squamocolumnar junction in the transformation 
zone” or “strikingly dense acetowhite areas in 
the columnar epithelium” or “condyloma and 
leukoplakia occurring close to the squamocolumnar 
junction turning intensely white” one minute after 
the application of a 5% acetic acid solution (15).
 Those who had overt lesions suspect for cancer 
were referred for further care at the closest tertiary 
centre(Kakamega provincial hospital and Moi referral 
hospital).A follow up call at one month was made to 
find out whether they had gone for further care or 
not and reasons recorded. 
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Flow Chart of Screened Participants
Total screened (109)
VIA/VILI Positive (21) VIA/VILI Negative (73) Excluded (15)
Suspicious of cervical cancer: 2
                    Prolapsed uterus: 2
                                 Declined: 11
Follow-up phone interview after one month (Determine compliance to referral
Regular check-upReferred for cryotherapy
(Phone not obtained)
RESULTS
We screened a total of one hundred and nine women 
who had availed themselves for a free medical camp. 
Majority of the women were in the age group of  26 
and 55 years.  Seventy two (72%) did not have any 
medical illnesses. Depo Provera was the most utilized 
form of contraception, 52% used no method at all. 
The population screened seemed to know their HIV 
status and spoke about it freely, Six patients who 
were HIV positive reported good follow-up at the 
nearest HIV clinics.
 Patients who screened  positive  for VIA/VILI 
were referred to tertiary facilities for cryotherapy. 
Out of the 21 patients referred, ten  (47.67%)were 
unreachable on phone to enquire about follow-up, 
Seven (33.33%) did not follow through. In total eighty 
point nine five percent  (80.95%) of women who had 
a positive VIA/VILI screen did not access cryotherapy 
treatment after referral.
Figure 1
Age distribution of women attending the medical camp for screening 
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Figure 4
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Table 1
Follow Up VIA/VILI Results
Further Rx (yes/no & 
where)
Type of Rx Reason for no Rx Follow up arranged/
advised
1 Yes Kakamega None -No doctor in clinic Advised to go back for 
follow up in 3 months. 
2 No - Financial -
3 Yes, Kakamega G i v e n  o r a l 
medication
- Advised on followup 
visit in 2 months
4 No - Time (still plans to go) -
5 No - Financial -
6 Phone not in use
7 Phone not in use
8 No Separated from husband , 
Husband has phone and no 
idea on her  whereabouts
9 Yes (Kakamega) Lab tests Doctor not available  on 
scheduled clinic day for 
review
Advised to book clinic 
in 2 months
10 No - Financial constraints -
11 No - Financial constraints -
12 Yes(Kakamega) Repeat VIA Went to both Kakamega and 
Busia district hospitals.Told 
she was ok
-
13 No None Financial constraints -
14 No None Financial constraints -
15 Phone not in use - - -
16 Phone not in  use - - -
17 Phone not in use - - -
18 Phone not in use - - -
19 Phone not in use - - -
20 Phone  not in use - - -
21 Phone not in use - - -
DISCUSSION
Cervical cancer screening in developing countries 
is still a mirage and requires sustainable, affordable 
and feasible framework to deliver these services 
(7), the number of deaths annually due to cervical 
cancer can be prevented through VIA VILI and 
timely cryotherapy.  Cryotherapy is carried out 
using a variety of cryotherapy devices that utilise 
frozen nitrogen or carbon dioxide gas and applied on 
suspicious positive lesions after a positive screening 
test . 
 Cryotherapy machines in the health centre 
where the medical camp was held were broken 
down, instantly paralysing interventions for 
positive lesions  requiring cryotherapy. Various 
types of machines have been utilised with different 
operational difficulties encountered, for example the 
Wallach cryotherapy equipment had a design flaw 
which caused temperatures above −20°C that led to 
product recall, and breakage without the availability 
of adequate repair and maintenance training (23). 
Details of machine breakdown at the health center 
could not be ascertained due to inaccessibility to the 
maintenance team at the health centre as well as poor 
understanding of machine breakdown intricacies. 
Good reliable reporting systems are required to 
facilitate timely repair and maintenance , healthcare 
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providers additionally require training on trouble 
shooting when machines malfunction as part of the 
training package.
 Financial constraints was the leading cause for 
lack of follow up,  millennium development goal 
one to eradicate extreme poverty and hunger by 
2015 estimated that even by 2015  over 900 million 
people will still be living on less than one dollar a 
day (24) ; re-emphasising that  extreme poverty  will 
adversely affect healthcare seeking behaviour and 
worsen the vicious cycle of poor adherence to  care 
;this is echoed in Western Kenya where travel costs 
was  among the  leading cause of lack of follow up 
in a similar setting (21).
 Patient comprehension of cervical cancer  is 
still poor, most women will not report to the clinic 
for screening  due to  the deceptive painless clinical 
course of the pre-cancerous stage (16),free medical 
camps offer healthcare providers a spring board to 
initiate the screening process  and additionally offer 
patients counselling and knowledge about the disease. 
We noted   procrastination of treatment by 4.8% of 
participants after referral.  
 Kenya is way below the recommended WHO 
doctor to patient ratio of 1 in 1000 (25). With 
approximately 40 million Kenyans, Kenya requires 
40,000 doctors to meet that ratio. Among reasons 
for lack of follow up were unavailable healthcare 
personnel  to review patients after referral; training 
and handsome incentivising of healthcare workers 
is key in the sustenance of service provision in rural 
areas of the country,  the current total number of 
doctors is approximately 8,000 with  approximately 
2300 of them being in the public health sector. Even 
among the few in the public health sector, majority 
tend to conglomerate in the urban centers leaving 
rural Kenya in a perpetual health crisis (26).  This 
emphasizes the need for health care providers at the 
primary setting i.e., nurses, and medical officers  in 
dispensaries and subdistrict hospitals to not only be 
trained to perform both VIA/VILI and Cryotherapy 
but also be provided with the cryotherapy equipment 
to treat positive lesions immediately. VIA VILI and 
cryotherapy should be within walking distances to 
eliminate the factors identified in this report for lack 
of followup for cryotherapy-money for transport, 
time, procrastination  and unavailability of doctors.
 It is imperative to invest in public awareness so 
as to empower  patients on timely healthcare seeking. 
It is key to assess patients knowledge, attitudes and 
practices regarding cervical cancer and treatment 
modalities to set the stage for focused interventions. 
 A limitation of this report is that a majority 
of participants (42.9%) could not be contacted due 
to communication challenges as phones were no 
longer in use thus unable to ascertain their follow up. 
This limitation of phone access stresses the need for 
immediate and accessible treatment with cryotherapy 
to minimise issues associated with follow up and 
referrals.
 The good old pap smear initiated by Papanicolaou 
and Traut in 1941 is still not accessible to majority of 
women in poor resource settings due to cost, need 
for pathological assessment and further follow up 
appointments. The use of VIA/VILI is a simple, 
cost effective method that does not require the 
aforementioned pre requisites as in papsmear, but 
treatment of dysplasia by cryotherapy  is faced 
with many logistical challenges. We noted  financial 
restrictions (28.6%),  intentional postponement of 
care after referral ( 4.8%) and unavailable  doctor for 
review(9.5%)  as major contributors to lack follow up.
In conclusion, cervical cancer is a public health 
problem in both developed and developing countries 
but is preventable and curable if identified at an early 
stage. It is the second most common cancer among 
women worldwide. Bridging the gap is paramount 
in heathcare service provision, patients need to be 
empowered on timely healthcare seeking,  while 
government need to sustain services by enabling 
healthcare workers provide services in the most 
remote parts of the country.  Strategies to eradicate 
poverty  are required to help Kenya achieve 
millennium development goal one  and by extension 
empower Kenyans to seek healthcare timely without 
hefty financial constraints. 
 There is urgent need for well maintained 
cryotherapy machines and training of personnel 
to perform cryotherapy at the primary care level. 
VIA VILI is an acceptable screening modality in 
resource poor settings, but without local availability 
of cryotherapy machines to treat dysplasia, the 
incidence of cervical cancer cases will not change. 
Multi regional studies on knowledge attitudes and 
practices about VIA/VILI and cryotherapy may 
offer targeted solutions for women and increase the 
uptake of this procedure for early diagnosis and 
timely treatment. 
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